Expleo Solutions Ltd Stock Price Today (NSE: EXPLEOSOL)
Fundamental Score
Expleo Solutions Ltd Share Price Live NSE/BSE & Institutional Fundamental Analysis
Expleo Solutions Ltd share price today is ₹850.05, up +0.00% on NSE/BSE as of 17 February 2026. Expleo Solutions Ltd (EXPLEOSOL) is a Small-cap company in the IT Enabled Services sector with a market capitalisation of ₹1.69K (Cr). The 52-week high for EXPLEOSOL share price is ₹N/A and the 52-week low is ₹N/A. At a P/E ratio of 16.20x, EXPLEOSOL is currently trading below its industry average P/E of 33.81x. The company has a Return on Equity (ROE) of 16.26% and a debt-to-equity ratio of 0.03.
Expleo Solutions Ltd Share Price Chart — NSE/BSE Historical Performance
Returns & Performance
ROE
ROCE
OPM (5Y)
Div Yield
Expleo Solutions Ltd Valuation Check
P/E Ratio
Industry P/E
Market Cap
Growth Engine
Profit Growth (Q)
Sales Growth (Q)
Sales Growth (5Y)
EPS Growth (5Y)
Profit Growth (5Y)
Balance Sheet Health
Debt to Equity
Int. Coverage
Free Cash Flow (5Y)
Shareholding
Promoter
FII
DII
Pledged
Institutional Deep-Dive
Bull Run Research Hub
Expleo Solutions Share Price Analysis: A ROCE-Driven Perspective
The IT Enabled Services (ITES) sector is currently experiencing a significant shift towards specialized consulting and digital transformation, demanding higher levels of operational efficiency and capital allocation. This analysis focuses on the Expleo Solutions share price, currently at ₹874.0, and examines its financial health through the lens of Return on Capital Employed (ROCE) efficiency. With a PE ratio of 16.2 and a ROCE of 21.47%, Expleo Solutions presents an interesting case within its peer group.
A critical metric for evaluating a company's long-term viability, ROCE reflects how effectively a company utilizes its capital to generate profits. Expleo Solutions' ROCE of 21.47% suggests a relatively strong capacity for profit generation compared to its investments. This high ROCE contributes significantly to building a wider economic moat around the company, making it more difficult for competitors to erode its market share and profitability. A consistent high ROCE is often indicative of efficient operations, strong management, and a defensible business model.
Comparing Expleo Solutions to its sector peers, such as
FCS Software Solutions Ltd, requires a deeper dive. While financial metrics offer a quantitative comparison, qualitative factors like management quality play a crucial role. For instance, an observation might be that, relative to FCS Software Solutions Ltd, Expleo's management demonstrates a potentially superior capital allocation strategy as reflected in its ROCE, leading to a greater creation of shareholder value over the long term. Such differences, even if subtle, influence investor sentiment and ultimately, stock valuation. Further investigation into the cash conversion cycle and working capital management would provide added color.The current PE ratio of 16.2 suggests that the market is valuing Expleo Solutions at a moderate premium relative to its earnings. However, this valuation needs to be considered in conjunction with the ROCE. The high ROCE may justify a higher PE ratio compared to peers with lower returns on capital. It is important to note that this analysis is part of a comprehensive 80-parameter fundamental audit verified by Sweta Mishra, ensuring a rigorous and multi-faceted assessment. This analysis uses publicly available data and is purely observational, offering no specific buy or sell recommendations.
Labels (e.g., "Excellent", "Good") are peer-based vs industry/sector averages — data-only, not advice
Expleo Solutions Ltd Fundamental Analysis & Valuation Benchmarking
Educational evaluation of EXPLEOSOL across key market metrics for learning purposes.
Positive Indicators
12 factors identified
Strong Return on Equity (16.26%)
Observation: Efficient use of shareholders' capital generating superior returns.
Analysis: ROE >15% indicates strong profitability and effective management. This metric suggests the company can generate substantial returns on invested capital.
Excellent ROCE Performance (21.47%)
Observation: Superior returns on capital employed across business operations.
Analysis: ROCE >15% demonstrates efficient capital deployment and strong operational performance.
Strong Operating Margins (17.99%)
Observation: Healthy 5-year operating margins indicate pricing power and cost control.
Analysis: OPM >15% suggests operational efficiency and competitive advantages.
Attractive Valuation (P/E: 16.20 vs Industry: 33.81)
Observation: Trading at discount to industry peers.
Analysis: P/E below industry average may present value opportunity.
Consistent Growth Track Record (30.55% CAGR)
Observation: Strong 5-year sales compound annual growth rate.
Analysis: Consistent sales CAGR >12% demonstrates sustainable growth model.
Strong Profit Growth Track Record (20.52% CAGR)
Observation: Consistent 5-year profit compound annual growth rate.
Analysis: Profit CAGR >15% demonstrates scalable business model.
Conservative Debt Levels (D/E: 0.03)
Observation: Low leverage provides financial flexibility and reduced risk.
Analysis: Conservative debt structure offers resilience during economic downturns.
Strong Interest Coverage (50.34x)
Observation: Earnings comfortably cover interest obligations.
Analysis: Interest coverage >5x indicates low financial distress risk.
Strong Cash Generation (₹266.89 Cr over 5Y)
Observation: Healthy free cash flow generation supports growth and returns.
Analysis: Strong FCF provides flexibility for dividends, debt reduction, and growth investments.
Balanced Promoter Holding (71.05%)
Observation: Optimal balance between promoter control and public float.
Analysis: Promoter holding in 50-75% range provides management alignment.
Zero Share Pledging Risk
Observation: No promoter shares pledged as collateral.
Analysis: Absence of share pledging eliminates potential forced-selling pressure.
Attractive Dividend Yield (4.61%)
Observation: Healthy dividend yield provides income component to returns.
Analysis: Dividend yield >3% offers income potential while indicating cash flow strength.
Risk Factors
1 factors identified
Limited Institutional Interest (FII+DII: 0.97%)
Observation: Low institutional participation may affect liquidity.
Analysis: Limited institutional interest may indicate size constraints or visibility issues.
Expleo Solutions Ltd Financial Statements
Comprehensive financial data for Expleo Solutions Ltd including income statement, balance sheet and cash flow
About EXPLEOSOL (Expleo Solutions Ltd)
Expleo Solutions Ltd (EXPLEOSOL) is listed on the National Stock Exchange (NSE) and Bombay Stock Exchange (BSE) of India. The company operates in the IT Enabled Services sector with a current market capitalisation of ₹1.69K (Cr). Expleo Solutions Ltd has delivered a Return on Equity (ROE) of 16.26% and a ROCE of 21.47%. The debt-to-equity ratio stands at 0.03, reflecting the company's capital structure. Investors tracking EXPLEOSOL share price can monitor key metrics including P/E ratio, promoter holding of 71.05%, and quarterly earnings growth.
Company Details
Key Leadership
Corporate Events
EXPLEOSOL Share Price: Frequently Asked Questions
What is the current share price of Expleo Solutions Ltd (EXPLEOSOL)?
As of 17 Feb 2026, 10:10 am IST, Expleo Solutions Ltd share price is ₹850.05. The EXPLEOSOL stock has a market capitalisation of ₹1.69K (Cr) on NSE/BSE.
Is EXPLEOSOL share price Overvalued or Undervalued?
EXPLEOSOL share price is currently trading at a P/E ratio of 16.20x, compared to the industry average of 33.81x. Based on this relative valuation, the Expleo Solutions Ltd stock appears to be Undervalued against its sector peers.
What is the 52-week high and low of EXPLEOSOL share price?
The 52-week high of EXPLEOSOL share price is ₹N/A and the 52-week low is ₹N/A.
What factors affect the Expleo Solutions Ltd share price?
Key factors influencing EXPLEOSOL share price include quarterly earnings growth (Sales Growth: 9.04%), raw material costs, government infrastructure spending, and institutional flows (FII/DII holding).
Is Expleo Solutions Ltd a good stock for long-term investment?
Expleo Solutions Ltd shows a 5-year Profit Growth of 20.52% and an ROE of 16.26%. Long-term investors should consider these fundamentals alongside the debt-to-equity ratio of 0.03 before investing in EXPLEOSOL shares.
How does Expleo Solutions Ltd compare with its industry peers?
Expleo Solutions Ltd competes with major peers in the IT Enabled Services. Investors should compare EXPLEOSOL share price P/E of 16.20x and ROE of 16.26% against the industry averages to determine competitive standing.
What is the P/E ratio of EXPLEOSOL and what does it mean?
EXPLEOSOL share price has a P/E ratio of 16.20x compared to the industry average of 33.81x. Investors pay ₹16 for every ₹1 of annual earnings.
How is EXPLEOSOL performing according to Bull Run's analysis?
EXPLEOSOL has a Bull Run fundamental score of 60.3/100, indicating moderate strength with some areas for improvement. This comprehensive rating is based on 15+ financial parameters.
What sector and industry does EXPLEOSOL belong to?
EXPLEOSOL operates in the IT Enabled Services industry. This classification helps understand the competitive landscape and sector-specific trends affecting Expleo Solutions Ltd share price.
What is Return on Equity (ROE) and why is it important for EXPLEOSOL?
EXPLEOSOL has an ROE of 16.26%, which indicates excellent management efficiency. ROE measures how efficiently Expleo Solutions Ltd generates profits from shareholders capital.
How is EXPLEOSOL debt-to-equity ratio and what does it indicate?
EXPLEOSOL has a debt-to-equity ratio of 0.03, which indicates conservative financing with low financial risk.
What is EXPLEOSOL dividend yield and is it a good dividend stock?
EXPLEOSOL offers a dividend yield of 4.61%, meaning you receive ₹4.61 annual dividend for every ₹100 invested in Expleo Solutions Ltd shares.
How has EXPLEOSOL share price grown over the past 5 years?
EXPLEOSOL has achieved 5-year growth rates of: Sales Growth 30.55%, Profit Growth 20.52%, and EPS Growth 10.93%.
What is the promoter holding in EXPLEOSOL and why does it matter?
Promoters hold 71.05% of EXPLEOSOL shares, with 0.00% pledged. High promoter holding often indicates strong management confidence in Expleo Solutions Ltd.
What is EXPLEOSOL market capitalisation category?
EXPLEOSOL has a market capitalisation of ₹1686 crores, placing it in the Small-cap category.
How volatile is EXPLEOSOL stock?
EXPLEOSOL has a beta of N/A. A beta > 1 suggests the Expleo Solutions Ltd stock is more volatile than the market, while a beta < 1 suggests it is less volatile.
What is EXPLEOSOL operating profit margin trend?
EXPLEOSOL has a 5-year average Operating Profit Margin (OPM) of 17.99%, indicating the company's operational efficiency.
How is EXPLEOSOL quarterly performance?
Recent quarterly performance shows Expleo Solutions Ltd YoY Sales Growth of 9.04% and YoY Profit Growth of 12.03%.
What is the institutional holding pattern in EXPLEOSOL?
EXPLEOSOL has FII holding of 0.13% and DII holding of 0.84%. Significant institutional holding often suggests professional confidence in the Expleo Solutions Ltd stock.